| ISIN | LI0012960956 |
|---|---|
| Valor Number | 1296095 |
| Bloomberg Global ID | |
| Fund Name | Aquila International Fund - Corby Swiss Equity (CHF) |
| Fund Provider |
Aquila AG
Zürich, Switzerland Phone: +41 58 680 60 00 Web: www.aquila.ch |
| Fund Provider | Aquila AG |
| Representative in Switzerland |
LLB Swiss Investment AG Zürich |
| Distributor(s) | LB (Swiss) Investment AG |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Liechtenstein |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 2,803.20 CHF | 14.11.2025 |
|---|---|---|
| Previous Price * | 2,825.73 CHF | 13.11.2025 |
| 52 Week High * | 2,878.50 CHF | 19.08.2025 |
| 52 Week Low * | 2,377.05 CHF | 09.04.2025 |
| NAV * | 2,803.20 CHF | 14.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 68,958,395 | |
| Unit/Share Assets *** | 65,302,583 | |
| Trading Information SIX | ||
| YTD Performance | +6.94% |
31.12.2024 - 14.11.2025
31.12.2024 14.11.2025 |
|---|---|---|
| 1 month | -0.03% |
14.10.2025 - 14.11.2025
14.10.2025 14.11.2025 |
| 3 months | -1.72% |
14.08.2025 - 14.11.2025
14.08.2025 14.11.2025 |
| 6 months | +1.01% |
14.05.2025 - 14.11.2025
14.05.2025 14.11.2025 |
| 1 year | +4.98% |
14.11.2024 - 14.11.2025
14.11.2024 14.11.2025 |
| 2 years | +24.65% |
14.11.2023 - 14.11.2025
14.11.2023 14.11.2025 |
| 3 years | +26.11% |
14.11.2022 - 14.11.2025
14.11.2022 14.11.2025 |
| 5 years | +28.58% |
16.11.2020 - 14.11.2025
16.11.2020 14.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Novartis AG Registered Shares | 6.23% | |
|---|---|---|
| UBS Group AG Registered Shares | 5.89% | |
| ABB Ltd | 5.49% | |
| Nestle SA | 5.28% | |
| Roche Holding AG | 5.28% | |
| Accelleron Industries AG Ordinary Shares | 5.04% | |
| Lonza Group Ltd | 4.78% | |
| Compagnie Financiere Richemont SA Class A | 4.70% | |
| Swissquote Group Holding SA | 4.38% | |
| Swiss Re AG | 3.83% | |
| Last data update | 30.09.2025 | |
| TER *** | 1.83% |
|---|---|
| TER date *** | 31.12.2024 |
| Performance Fee *** | 10.00% |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | 1.80% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |